(Reuters)
World
Shire sells cancer drugs to Servier
A $2.4-billion deal between London-based rare disease specialist Shire and French drugmaker Servier could threaten a merger between Shire and Japanese pharmaceutical company Takeda.
Read More
Up next in World
promo
1:20
Shire sells cancer drugs to Servier
promo
1:16
Putin: 'Everyone will notice' Russia's response to downing of plane
promo
1:06
Retrieval efforts underway for trapped people in northern Philippines landslide
promo
0:50
Hong Kong building partially crumbles after Typhoon Mangkhut hits
promo
1:45
Super typhoon Mangkhut wreaks havoc in Hong Kong
promo
2:41
What to know about the next stage of the Syrian War
promo
0:47
Typhoon strikes Hong Kong after killing dozens in Philippines
promo
4:31
The Oslo Accords, 25 years later
promo
3:28
Key moments from Bolton's speech at the Federalist Society
promo
3:45
How the world learned about Novichok, Russia’s secret, deadly nerve agent
promo
2:51
Sweden's far right gains momentum as crime becomes hot-button issue
promo
1:13
Indian Supreme Court decriminalizes gay sex
promo
0:48
Bobi Wine sings excerpt from song ‘Freedom’
promo
2:07
Bobi Wine says he was 'brutalized' by Ugandan military
promo
3:41
May: Two Russian military intelligence officers behind Skripal poisoning
promo
1:27
Pompeo meets with Imran Khan amid heightened U.S.-Pakistan tension
promo
1:11
Prince Harry joins Lin-Manuel Miranda onstage at 'Hamilton'
promo
1:19
Germany's far-right blamed for protests turning violent
promo
1:43
Seven times world leaders made headlines with their dance moves
promo
0:59
Merkel condemns deadly stabbing, xenophobic riots
promo
1:39
The pope's first day in Ireland, in less than 2 minutes